Sensei’s plans also include a potential expansion into infectious diseases. (Sensei Biotherapeutics) () Sensei Biotherapeutics has raised $28.5 million to advance a pipeline of personalized cancer ...
As the number of antibiotic-resistant infections continues to rise, scientists are looking to bacteriophages (“phages”), viruses that infect bacteria, as an approach to tackling antibiotic resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results